Publications
152
Citations
678
Est. group size
~2
Recurring co-author estimate
Active years
19
Publishing since 2008
Typically publishes in teams of ~17 · 6% small-team papers (≤3 authors) · across 41 venues
- Targeting BCMA in Plasmablastic Lymphoma With Teclistamab: A Case Study of Three Patients
Journal of the National Comprehensive Cancer Network · 2026
- Hematologic complications in patients exposed to poly-ADP ribose polymerase inhibitors
Haematologica · 2026
- Targeting Menin in T-lineage Acute Lymphoblastic Leukemia
Molecular Cancer Therapeutics · 2026
- Targeting the CD74 signaling axis suppresses inflammation and rescues defective hematopoiesis in <i>RUNX1</i> -familial platelet disorder
Science Translational Medicine · 2025
- The ethics of climate change and health-care delivery: a national survey of US-based physicians
The Lancet Planetary Health · 2025
- Outcomes of patients with relapsed/refractory acute leukaemia treated with revumenib with a focus on post‐revumenib therapies
British Journal of Haematology · 2025
- Incorporation of patient-reported outcomes in pediatric cancer clinical trials: design, implementation, and dissemination
JNCI Journal of the National Cancer Institute · 2025
- Outcomes of older patients with TP53-mutated myeloid neoplasms
Blood Cancer Journal · 2025
- Outcomes for Patients With Myeloid Neoplasms Treated With Chemotherapy Plus Venetoclax After Prior Venetoclax Therapy
eJHaem · 2025
- Primary efficacy analysis of phase II study investigating tyrosine kinase inhibitor (TKI) and inotuzumab ozogamicin-based therapy for newly diagnosed Philadelphia-chromosome positive acute lymphoblastic leukemia (Ph+ ALL)
Blood · 2025
- Patient-reported outcomes in physical, cognitive, and sexual health in early-onset gastrointestinal cancers (EOGIC).
Journal of Clinical Oncology · 2025
- Should we treat TP53-mutated high-risk myeloid neoplasms in older patients?
Journal of Clinical Oncology · 2025
- Choice of hypomethylating agent for newly diagnosed TP53-mutant Acute Myeloid Leukemia: A command registry study
Blood · 2025
- A Physical Therapy Screening Tool Utilizing the 6-Minute Walk Test Predicts Health Services Outcomes in Adult CAR-T Recipients.
Transplantation and Cellular Therapy · 2025
- Retrospective Analysis of Patients on PARP-inhibitors Referred for Bone Marrow Biopsy for Evaluation of Therapy-related Myeloid Neoplasms (Abstract ID: 161287)
Journal of Pharmacology and Experimental Therapeutics · 2025
- Blood×32
- Journal of Clinical Oncology×11
- Haematologica×4
- eJHaem×4
- Journal of Adolescent and Young Adult Oncology×4
- Chunhua Song
Medicine · The Ohio State University
- Nyla A. Heerema
Medicine · The Ohio State University
- Joshua W. Goldman
Medicine · University of Michigan
- Martina Fraga
Medicine · University of Michigan
- Shalini C. Reshmi
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile